New Clinical Anatomical Interpretation of COVID-19 Pandemic Infection

Al-Dorazi, Shorok; Al-Talalwah, Waseem

doi:10.4067/s0717-95022021000200635

Cited by 1 publication

(2 citation statements)

References 14 publications

(17 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Therefore, several mechanisms may explain trigeminal neuralgia in COVID-19. Al Dorazi & Al Talalwah (2021), COVID-19 may lead to vasculitis, resulting in thrombosis, which can damage the trigeminal nerve. The vessel is lined with a simple squamous endothelial cell as COVID-19 binds to the ACE2 receptor and result in endothelial damage, therefore, the cell does not produce nitric oxide and prostacyclin, which prevents thrombosis.…”

Section: Discussionmentioning

confidence: 99%

“…Recently, COVID-19 was found to be a risk factor for cerebral vein thrombosis when combined with a fungal infection or when coronavirus binds with ACE2 receptors, resulting in vasculitis (Al Dorazi & Al Talalwah, 2021). The cavernous sinus and vein are lined by simple squamous endothelial cells, and as COVID-19 binds to the ACE2 receptor, it results in endothelial injury therefore the cell does not produce nitric oxide and prostacyclin which prevent thrombosis.…”

Section: Based On Anatomical Interpretation Bymentioning

confidence: 99%

See 1 more Smart Citation

Trigeminal Neuralgia in COVID-19: A meta-analysis

Al-Talalwah

Al-Dorazi²

2023

Int. J. Odontostomat.

View full text Add to dashboard Cite

The trigeminal nerve is the fifth cranial nerve, which transmits facial sensations, and is divided into the ophthalmic, maxillary, and mandibular branches. Damage to this nerve can cause trigeminal neuralgia, a clinical condition that can also present in patients with coronavirus disease 2019 . This meta-analysis reviews the clinical cases of trigeminal neuralgia reported in patients with COVID-19 from 2019 to 2022, describes the anatomical mechanism of pain and its radiation and identifies other associated symptoms. We performed a literature search to identify reports of patients with COVID-19 who developed trigeminal neuralgia and examined these cases for prevalence and any identified source of associated ocular pain. Of the relevant studies identified, 638 patients with COVID-19 developed trigeminal neuralgia out of 7561 total COVID-19 cases (8.4 %). Of the 638 cases, 590 (7.8 %) had known causes of ocular pain, while the cause of ocular pain was unknown in 48 cases (0.6 %). Trigeminal neuralgia developed infrequently in patients with COVID-19, and cases with known causes of ocular pain were more common than cases with unknown causes. Understanding the link between COVID-19 and trigeminal neuralgia may lead to preventing further complications and mortality in these patients, as well as improving care for patients with these conditions in the future. Additionally, understanding these new clinical issues can prepare many types of physicians to protect themselves better in the event of a COVID-19 outbreak among medical staff in different departments of hospitals, such as clinics, wards, emergency rooms, and operating theatres.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Based On Anatomical Interpretation Bymentioning

confidence: 99%